Concepedia

M. Versola

MV

Statistics

Publications

16

Citations

503

H-Index

14

Active since

2003

Affiliations

GlaxoSmithKline (United States)(Current)

Sarah Cannon

Research Triangle Park Foundation

Brooke Army Medical Center

Tennessee Oncology

M. Versola is an author at GlaxoSmithKline (United States) specializing in oncology, medicine, and pharmacology.

Top concepts

Publications per year

2003–2013

16

Publications

16

A Phase I and Pharmacokinetic Study of Oral Lapatinib Administered Once or Twice Daily in Patients with Solid Malignancies

Howard A. Burris, Charles W. Taylor, Suzanne F. Jones et al. · Clinical Cancer Research · 2009 · 95 citations · Full text

Phase I and Pharmacokinetic Study of Lapatinib in Combination With Capecitabine in Patients With Advanced Solid Malignancies

Quincy S. Chu, Garry Schwartz, Johann S. de Bono et al. · Journal of Clinical Oncology · 2007 · 62 citations · Full text

A phase I and pharmacokinetic study of lapatinib in combination with infusional 5-fluorouracil, leucovorin and irinotecan

Rachel Midgley, Keith T. Flaherty, James Stevenson et al. · Annals of Oncology · 2007 · 53 citations

, , +7

Phase I Pharmacokinetic Study of the Safety and Tolerability of Lapatinib (GW572016) in Combination with Oxaliplatin/Fluorouracil/Leucovorin (FOLFOX4) in Patients with Solid Tumors

Wandena S. Siegel-Lakhai, Jos H. Beijnen, Walter L. Vervenne et al. · Clinical Cancer Research · 2007 · 47 citations

Clinical activity of GW572016 in EGF10003 in patients with solid tumors

M. Versola, H. A. Burris, Sharon Jones et al. · Journal of Clinical Oncology · 2004 · 40 citations

, , +15

1–5 of 16